JPMorgan Chase & Co’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Sell |
21,864
-4,259
| -16% | -$26.7K | ﹤0.01% | 4655 |
|
|
2025
Q1 | $153K | Sell |
26,123
-68,263
| -72% | -$400K | ﹤0.01% | 4552 |
|
|
2024
Q4 | $776K | Buy |
94,386
+40,884
| +76% | +$336K | ﹤0.01% | 3936 |
|
|
2024
Q3 | $477K | Buy |
53,502
+27,718
| +108% | +$247K | ﹤0.01% | 4038 |
|
|
2024
Q2 | $195K | Buy |
25,784
+1,499
| +6% | +$11.3K | ﹤0.01% | 4287 |
|
|
2024
Q1 | $191K | Buy |
24,285
+5,925
| +32% | +$46.5K | ﹤0.01% | 4474 |
|
|
2023
Q4 | $163K | Sell |
18,360
-281
| -2% | -$2.49K | ﹤0.01% | 4546 |
|
|
2023
Q3 | $167K | Sell |
18,641
-3,030
| -14% | -$27.2K | ﹤0.01% | 4331 |
|
|
2023
Q2 | $268K | Buy |
21,671
+3,173
| +17% | +$39.2K | ﹤0.01% | 4114 |
|
|
2023
Q1 | $171K | Buy |
18,498
+7,752
| +72% | +$71.7K | ﹤0.01% | 4401 |
|
|
2022
Q4 | $113K | Buy |
10,746
+733
| +7% | +$7.71K | ﹤0.01% | 4450 |
|
|
2022
Q3 | $181K | Buy |
10,013
+215
| +2% | +$3.89K | ﹤0.01% | 4216 |
|
|
2022
Q2 | $139K | Buy |
9,798
+7,170
| +273% | +$102K | ﹤0.01% | 4478 |
|
|
2022
Q1 | $58K | Sell |
2,628
-3,967
| -60% | -$87.6K | ﹤0.01% | 4957 |
|
|
2021
Q4 | $112K | Buy |
+6,595
| New | +$112K | ﹤0.01% | 4772 |
|